, and L3-ileocolonic) was compared with demographic features including age, race, ethnicity, smoking and infl ammatory bowel disease (IBD) family history, diagnosis age, disease duration, clinical outcomes of infl ammatory, stricturing or penetrating behavior, and CD abdominal surgeries. Univariate and multivariable analyses were performed with R.
INTRODUCTION
Crohn ' s disease (CD) results in transmural infl ammation involving the colon, the small intestine, and occasionally the stomach and esophagus. Systems to classify disease location include the Vienna and Montreal classifi cations. In 1998, Th e Vienna classifi cation was proposed ( 1 ) . Th e Vienna classifi cation classifi ed disease into four categories by location: L1, terminal ileum (TI) without colonic involvement; L2, colonic involvement without TI involvement; L3, ileocolonic disease involving both the TI and colon; and L4, disease proximal to the TI without TI or colonic involvement. Because many patients have both L1-L3 and L4 diseases, a new classifi cation system was proposed. In 2005, the Montreal working party reclassifi ed L4 disease as proximal disease that can coexist with L1-L3 disease ( 2 ) .
Disease site is associated with complicated disease and need for surgery. Ileal disease is associated with stricturing and fi stulizing CD phenotypes ( 3 ) . Ileal disease is also associated with the need for CD-related surgery including small bowel resection, strictureplasty, and abscess drainage ( 3 ) . Most patients with proximal disease also have concurrent ileal disease. Proximal disease has also been found to be a risk factor for complicated disease and need for surgery ( 4, 5 ) . However, the role of proximal disease, independent of ileal disease has not been examined. Additionally, among those with proximal disease, the contribution of esophagogastroduodenal (EGD) vs. jejunal involvement has not been evaluated.
We sought to examine the role of proximal CD on disease behavior and the need for abdominal surgery. We further aimed to examine the role of proximal CD with EGD involvement compared with jejunal disease. Finally, we aimed to examine the eff ect of EGD or jejunal disease independent of ileal involvement. We used a cross-sectional study design including information on disease location, behavior, and surgery from the NIDDK (National Institute of Digestive and Kidney Disease) Infl ammatory Bowel Disease Genetics Consortium (IBDGC) to achieve these aims.
METHODS

Population
We queried the phenotype database of the National Institute of Diabetes and Digestive and Kidney Diseases IBDGC repository ( 6, 7 ) . Th is is a large database of patients with diagnosis of infl ammatory bowel disease (IBD) recruited from the United States, Puerto Rico, and Canada for genetic research studies. Requirements for case recruitment are any patients with a confi rmed diagnosis of CD, ulcerative colitis, or IBD undetermined type according to standardized diagnostic criteria ( 6 ) . Phenotyping was performed by clinicians with experience in managing patients with IBD and was conducted according to an established Phenotype Operating Manual. Th e validity of the phenotype classifi cation using the defi nitions and procedures outlined in the manual was previously described ( 6 ) . We included CD patients recruited between January 2003 and December 2011 who had completed data on the presence or absence of all proximal disease locations (esophagus, stomach, duodenum, and jejunum) and who completed data to determine the presence and absence of disease in the ileum and colon (i.e., L1, L2, or L3 locations).
Phenotyping -disease location and behavior
Please refer to the phenotyping manual in Supplement information . For CD, disease location is confi ned to the maximal macroscopic involvement at any time during the disease course up to the time of phenotyping. Most patients were last phenotyped at the time of enrollment; very few patients (in our sample, only 2 % ) were rephenotyped aft er initial enrollment. Location is based on endoscopy (excluding wireless capsule endoscopy, which was not routinely available), radiographic (barium studies, computer tomography, and magnetic resonance imaging), and operative reports. Patients are phenotyped as to whether macroscopic disease is present, absent or unknown for any or all of the following sites: EGD, jejunal, ileal, colorectal, and perianal locations. In contrast to the Montreal and Vienna classifi cations, ileal disease site defi nes any area of ileal involvement, and is not limited to the TI. Absence of a particular disease site requires that the patients have manifested no evidence of macroscopic disease at one or more endoscopic and / or radiographic examinations of the site categorized. Otherwise location is coded as unknown. Notably, phenotyping is based on available data; testing is performed according to clinical indication (e.g., a patient without upper gastrointestinal symptoms would not necessarily undergo an upper endoscopy). Additionally, the details regarding the modalities used for phenotyping were not recorded on a patient-per-patient basis.
Disease behavior is classifi ed as B1 (infl ammatory -disease without evidence of stricture or penetrating disease), B2 (stricturing -constant luminal narrowing with prestenotic dilation and / or obstructive symptoms, but without penetrating disease), and B3 (penetrating -bowel perforation, intra-abdominal fi stula, infl ammatory mass or abscess not related to a post-operative complication) as described previously ( 2, 6 ) . For surgeries, data are collected on the number of abdominal surgeries (bowel resection, strictureplasty, or abscess drainage) and the number of years between diagnosis and the fi rst surgery.
Demographics
Demographic information was entered for each study subject on sex, year of birth, race, tobacco use, and ethnicity. Data on cases include date of diagnosis, duration of disease (time from diagnosis until most recent available medical records at the time of phenotyping), family history of IBD (fi rst degree relative with IBD), smoking status at the time of diagnosis, disease location, disease behavior, and surgical history.
Statistical analyses
Five main disease location comparisons were analyzed with the outcomes of stricturing disease and surgery. Th ese groups were age and disease duration by proximal disease status were compared with two-sided t -tests. Years from diagnosis to fi rst surgery were analyzed by log-rank test. Statistical signifi cance was designated as P < 0.01. Two-by-two and two-by-three comparison results for categorical variables were obtained by using Chi-squared tests. Finally, we created multivariable models of stricturing disease and surgery by proximal disease status and EGD vs. jejunal involvement (with or without distal disease) accounting for all potential confounders (age, sex, race, smoking status at diagnosis, IBD family history in parents, siblings, or children, and disease duration). All analyses were performed in R ( 8 ).
RESULTS
Characteristics of included patients by disease location
Th ere were 1,759 patients with non-L4 disease and 346 patients with L4 disease. Of these patients, 175 (51 % ) had L4-EGD disease, while 115 (33 % ) had L4-jejunal disease. Th e complete fl owchart of patients is presented in Figure 1 .
Proximal disease (any L4 disease) vs. non-L4 disease
Patients with L4 disease had an earlier age at diagnosis (21.2 vs. 25.4 years; P < 0.001) and were less likely to be smokers at the time of diagnosis (15 vs. 22 % ; P = 0.003) ( Table 1 ). L4 patients were less likely to have concurrent L2 disease (12 vs. 21 % ; P < 0.001) and were more likely to have stricturing (B2) behavior (32 vs. 23 % ; P < 0.001). Additionally, L4 patients were more likely to have had two or more abdominal surgeries than non-L4 patients (23 vs. 17 % ; P = 0.007). Because there were so few patients with isolated L4 disease (without concurrent L1-L3 disease, see Figure 1 ), this group was not analyzed separately.
L4-EGD disease vs. non-L4 disease
Patients with L4-EGD disease were younger at diagnosis (19.7 vs. 25.4 years; P < 0.001), had a shorter disease duration at phenotyping (7.0 vs. 10.1; P < 0.001), were less likely to be of Hispanic ethnicity (6 vs. 14 % ; P = 0.004), and had fewer abdominal surgeries (35 vs. 47 % ; P = 0.003) than patients with non-L4 disease ( Table 1 ) . Th e distribution of concurrent disease location (L1, L2, or L3) as well as disease behavior (B1, B2, or B3) showed no diff erences between cases with L4-EGD disease and those with non-L4 disease.
L4-jejunal disease vs. non-L4 disease
L4-jejunal patients were signifi cantly less likely to have concurrent colonic (L2) disease (3 vs. 21 % ; P < 0.001) than patients with non-L4 disease ( Table 1 ). Th ey were also more likely to have stricturing (B2) behavior (45 vs. 23 % ; P < 0.001) and less likely to have infl ammatory (B1) behavior (21 vs. 47 % ; P < 0.001); rates of penetrating disease were not diff erent. Finally, L4-jejunal patients were more likely to have had one or more abdominal surgeries (74 vs. 47 % ; P < 0.001) as well as multiple abdominal surgeries (38 vs. 17 % ; P < 0.001) than non-L4 patients. Th ere were 56 patients with both jejunal and EGD diseases. Th is group had disease behavior more consistent with L4-jejunal patients than L4-EGD patients (available upon request).
L4-jejunal vs. L4-EGD disease
Patients with L4-jejunal disease were more likely to have concurrent ileal (L1) disease (41 vs. 21 % ; P = 0.001), less likely to have concurrent colonic (L2) disease (3 vs. 21 % ; P < 0.001) ( Figure 2a ), more likely to have stricturing disease (45 vs. 18 % ; P < 0.001), less likely to have infl ammatory disease (21 vs. 57 % ; P < 0.001) ( Figure 2b ), and more likely to have had one or more (74 vs. 35 % ; P < 0.001) as well as multiple abdominal surgeries (38 vs. 14 % ; P < 0.001) ( Figure 2c ).
Role of L4-jejunal disease independent of ileal disease
Ninety-two percent of patients with L4-jejunal disease had concurrent ileal disease (either L1 or L3). We compared L4-jejunal disease patients who had concurrent L1 or L3 disease with non-L4 patients with L1 or L3 disease. In the Chi-squared model, patients with the L4-jejunal and ileal disease were still more likely to have stricturing behavior ( P < 0.001) in addition to multiple abdominal surgeries ( P < 0.001) than patients with ileal disease only.
Independent predictors of stricturing behavior and multiple abdominal surgeries
Two logistic regression models were created to calculate risks of stricturing (B2) behavior ( Table 2 ) and two or more abdominal surgeries ( Table 3 ). Statistically signifi cant independent risk factors for stricturing behavior were ileal involvement (odds ratio (OR) 3.18; 95 % confi dence interval 2.23 -4.64), longer duration of disease (OR 1.33 per decade; 1.19 -1.49 ), L4-jejunal disease Longer duration of time from diagnosis to the fi rst surgery was protective (OR 0.87 per decade; 0.84 -0.90). Results were similar for independent predictors of one or more abdominal surgeries (available upon request). L4-EGD disease was neither predictive of stricturing disease nor multiple abdominal surgeries ( P = 0.39 and P = 0.30, respectively).
DISCUSSION
Patients with L4 disease were more likely to have stricturing behavior and multiple abdominal surgeries than patients with non-L4 disease. Th is association was only observed among patients with jejunal involvement (L4-jejunal) and not in patients with L4-EGD involvement. Furthermore, patients with L4-jejunal disease had higher rates of stricturing behavior and multiple abdominal surgeries than those with non-L4 ileal disease. In a logistic regression model, longer disease duration as well as L4-jejunal disease were independent risk factors for both stricturing disease and multiple abdominal surgeries. By contrast, L4-EGD disease was not predictive for these outcomes. Although currently grouped together by the Montreal classification system as L4 disease, the natural history of L4-EGD and L4-jejunal disease is very diff erent from one another. Only the latter is predictive of stricturing complications and need for multiple surgeries. For this reason, we propose that the Montreal Classifi cation should be amended to refl ect this important diff erence. In part based upon a preliminary report of these fi ndings ( 9 ), the recent proximal to the TI, proximal disease was the only signifi cant positive predictor for combined surgical and non-surgical disease recurrence in a Cox proportional hazard model ( P < 0.01). Th ese fi ndings were echoed in a cohort of 132 Chinese patients with CD, 30 (23 % ) of who had L4 disease at diagnosis based on the Montreal classifi cation ( 5 ). L4 phenotype was found to be associated with more stricturing (47 % ) and penetrating disease (30 % ) behavior than patients with non-L4 disease (19 and 4 % , respectively; P < 0.001), and patients with L4 disease were more likely to undergo major surgery (67 % ) than those without L4 disease (37 % ) ( P < 0.001). In a Cox proportional hazard model, L4 disease independently predicted hospitalization but not the need for major surgery. Finally, other studies have observed that patients with jejunoileal disease are more likely to require aggressive medical and nutritional therapy ( 13, 14 ) . Our study, with >10-fold the number of L4 patients than other reports, was the only study to divide proximal (L4) disease into EGD vs. jejunal involvement. By making this separation, we were able to show that overall predisposition of proximal disease toward greater risk of stricturing behavior and more surgery was solely due to the approximately two-fi ft hs of L4 patients with jejunal involvement. As previously noted, in contrast to the Vienna and Montreal classifi cations, the IBDGC phenotyping manual did not include ileal disease proximal to the TI as L4 disease. Th is was a matter of practicality: phenotyping for ileal site was primarily by small bowel series radiographic reports and in many cases, these reports do not distinguish the portion of ileum where disease involvement was found. By contrast, it is usually clear when disease involves the jejunum radiographically, and this site specifi city is usually detailed in radiographic reports. By identifying jejunal disease as predictive of stricturing disease and multiple surgeries, a unique at-risk group has been identifi ed. It is unknown whether proximal ileal disease would also have an independent risk of stricturing and multiple surgeries as we found for jejunal disease. Making this determination would likely require primary review of radiographs, ideally in a prospectively phenotyped cohort.
Our fi ndings are important for two reasons. First, it may impact design and interpretation of future studies with regard to Paris classifi cation of pediatric CD has incorporated this separation whereby L4a represents disease that is proximal to the ligament of Treitz while L4b represents disease that is distal to the ligament of Treitz and proximal to the distal one-third of the ileum ( 10 ) .
Th e overall rates of L4 disease observed in the IBDGC cohort (16 % ) are similar to that found in other studies. Rates of macroscopic gastroduodenal disease seen in a large pediatric cohort ( 11 ) ranged between 5 and 13 % , while in a population cohort study of children and adults in Denmark disease proximal to the ileum was found in 8 -19 % of CD patients ( 12 ) . Likewise, other studies have found evidence that L4 disease may carry a predisposition for more aggressive disease. Wolters et al ( 4 ) prospectively studied 358 patients with CD beginning from diagnosis and examined the relationship between phenotype at diagnosis (based on the Vienna classifi cation) and disease recurrence. Although only 20 (6 % ) patients had disease proximal disease site correlations with genotypes, serology, and other biomarkers. Second, patients with L4-jejunal disease may be an attractive at-risk target population for future studies of " topdown " approaches to medical management of CD because of their high rates of requiring multiple abdominal surgeries. Although we found a strong association between jejunal involvement and stricturing disease multiple abdominal surgeries, causality remains unclear. Patients with jejunal CD could be uniquely prone to the development of strictures in the jejunum; however, there is no obvious mechanical or pathophysiologic reason why jejunal disease should be any diff erent from ileal disease. A more likely explanation is that jejunal disease is a marker for more extensive small bowel involvement. Th e high rate of concurrent ileal disease among L4-jejunal patients further supports this theory but this needs to be confi rmed by independent studies. Note that the eff ect of L4-jejunal disease on multiple surgeries was not a result of requiring earlier surgical intervention: time from diagnosis to fi rst surgery for L4-jejunal patients was no shorter than that for L4-EGD or non-L4 patients.
Notably, smoking at the time of diagnosis was not found to be an independent risk factor for either stricturing behavior or multiple abdominal surgeries. Prior studies have shown smoking strongly associated with both outcomes ( 15, 16 ) . Univariate analysis did fi nd that smoking at diagnosis is strongly associated with both stricturing behavior (OR 1.59 (1.22 -2.09), P = 0.001) and multiple abdominal surgeries (OR 1.97 (1.53 -2.53), P < 0.001). However, because smoking was also highly associated in univariate analyses with disease duration, greater age at diagnosis, and penetrating disease, it did not show up as an independent predictor in multivariable analyses.
Limitations
Th e modalities used for phenotyping were not recorded on a patient-by-patient basis. Instead, tests were performed based on clinical indication. Because not all patients underwent the most sensitive test available for picking up disease in a given location, rates of L4-jejunal disease were probably underestimated. However, the disease that was detected was probably more clinically relevant. Furthermore, rates of detecting L4-jejunal Crohn ' s did not increase over time as one might predict with the adoption of newer more sensitive imaging techniques such as computer tomography or magnetic resonance enterography (data available upon request). Other limitations include (i) inter-rater reliability was found to be only fair for EGD disease (Kappa statistic 0.36) ( 6 ) . By contrast, inter-rater reliability for jejunal disease was rated as good with an overall Kappa statistic of 0.66, similarly to ileal and colonic disease, and (ii) because most patients were only phenotyped on one occasion, it is possible that L4 disease developed aft er requiring abdominal surgery; however, we think this scenario would be atypical.
In conclusion, the disease course of patients with L4 disease differs signifi cantly depending on whether or not the disease involves the jejunum. L4-jejunal disease, but not L4-EGD was independently predictive of stricturing phenotype and multiple abdominal surgeries. We therefore recommend that the Montreal classifi cation for adults be modifi ed to separate L4 disease into diff erent subcategories. 
